These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 11474769)
1. The role of new antiepileptic drugs. French JA Am J Manag Care; 2001 Jul; 7(7 Suppl):S209-14. PubMed ID: 11474769 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660 [TBL] [Abstract][Full Text] [Related]
3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822 [TBL] [Abstract][Full Text] [Related]
5. New antiepileptic drugs in pediatric epilepsy. Hwang H; Kim KJ Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659 [TBL] [Abstract][Full Text] [Related]
7. Some common issues in the use of antiepileptic drugs. Asconapé JJ Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy. Otoul C; Arrigo C; van Rijckevorsel K; French JA Clin Neuropharmacol; 2005; 28(2):72-8. PubMed ID: 15795549 [TBL] [Abstract][Full Text] [Related]
9. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. White HS Epilepsia; 1999; 40 Suppl 5():S2-10. PubMed ID: 10530688 [TBL] [Abstract][Full Text] [Related]
10. [Antiepileptic drugs in North America]. Akiyama T; Otsubo H Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099 [TBL] [Abstract][Full Text] [Related]
11. [Newer antiepileptic drugs]. Matsuura M No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756 [TBL] [Abstract][Full Text] [Related]
13. Epilepsy in children: the evidence for new antiepileptic drugs. Verdru P Acta Neurol Scand Suppl; 2005; 181():17-20. PubMed ID: 16238703 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821 [TBL] [Abstract][Full Text] [Related]
15. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366 [TBL] [Abstract][Full Text] [Related]
16. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Montouris G; Abou-Khalil B Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728 [TBL] [Abstract][Full Text] [Related]
18. Investigational antiepileptic drugs for the treatment of childhood seizure disorders: a review of efficacy and safety. Shields WD Epilepsia; 1994; 35 Suppl 2():S24-9. PubMed ID: 8275978 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin. Laxer KD West J Med; 1994 Sep; 161(3):309-14. PubMed ID: 7975572 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Gamble C; Williamson PR; Chadwick DW; Marson AG Neurology; 2006 May; 66(9):1310-7. PubMed ID: 16682660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]